1951 — Jinxin Fertility Income Statement
0.000.00%
Last trade - 00:00
- HK$6.67bn
- HK$8.70bn
- CNY2.79bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,648 | 1,426 | 1,839 | 2,364 | 2,789 |
Cost of Revenue | |||||
Gross Profit | 817 | 566 | 771 | 874 | 1,175 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,091 | 1,064 | 1,350 | 2,134 | 2,250 |
Operating Profit | 557 | 363 | 489 | 231 | 539 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 548 | 349 | 458 | 154 | 464 |
Provision for Income Taxes | |||||
Net Income After Taxes | 421 | 260 | 354 | 118 | 347 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 410 | 252 | 340 | 121 | 345 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 410 | 252 | 340 | 126 | 335 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.208 | 0.1 | 0.136 | 0.057 | 0.131 |
Dividends per Share |